Additionally, AR is associated with COVID-19 comorbidities (Dolan et al., 2020), and recently implicated in the severity of COVID-19 in women with polycystic ovarian syndrome, a disorder associated with high androgen levels and androgen sensitivity (Gotluru et al., 2021). The gene discussed is AR; the disease is COVID-19.